Evidence map›Paper›PMID 29719847›Full record

ArticleBulletin of emergency and trauma2018

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

Abbas Rasouli, Seyed Mojtaba Hosseini, Mohammadkarim Bahadori, Ramin Ravangard

Abstract read
In one paragraph

Article in Bulletin of emergency and trauma, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abbas RasouliDepartment of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Seyed Mojtaba HosseiniDepartment of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Mohammadkarim BahadoriHealth Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Ramin RavangardHealth Human Resources Research Center, School of Management and Medical Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

methodsThis was a cross-sectional study conducted in a Pharmaceutical Company in Iran in 2017. All employees working in the administrative, production, installations and facilities, and laboratory units were studied using the consensus method (N=n=130 employees). A data collection form was designed for identifying the hazards using the Nominal Group Technique (NGT) method, as well as a pair-wise questionnaire was used for collecting required data in the quantitative phase. The collected data were analyzed using Expert Choice 10.0 and SPSS 23.0.

resultsThe results showed that among hazards detected in the studied units, the highest and lowest weights and priorities were, respectively, related to "inhalation of toxic gases" (W=0.253) and "being exposed to radiation" (W=0.022) in the laboratory unit, "skin injuries" (W=0.205) and "bending and straightening for a long time" (W= 0.032) in the production unit, "falling down" (W=0.271) and "standing and sitting for a long time " (W=0.037) in the installations and facilities unit, and "hand joint failure" (W=0.295) and "working in a low-light environment" (W=0.092) in the administrative unit.

conclusionThe results of the present study showed that there were hazards in all of the studied units. These results indicated a high level of hazards in the pharmaceutical company's units. Due to the increased medication diversification and increased workload for these companies, paying attention to the preventive and corrective measures in order to reduce the risk of emerging hazards is essential.

Indexed as

Analytical Hierarchy Process (AHP)IranOccupational hazardsPharmaceutical companySafety

Identifiers

PMID29719847
PMCPMC5928273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.